Vitamin A supplementation for children with idiopathic scoliosis
Effect of Vitamin A Supplementation on the Onset and Progression of Idiopathic Scoliosis: A Prospective, Single-Blind, Randomized Controlled Trial
This test gives daily vitamin A to children with idiopathic scoliosis who have low vitamin A to see if it reduces curve size or prevents new curves.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 140 (estimated) |
| Ages | 6 Years to 15 Years |
| Sex | All |
| Sponsor | Second Affiliated Hospital of Wenzhou Medical University Academic / other |
| Locations | 1 site (Wenzhou, Zhejiang) |
| Trial ID | NCT07335991 on ClinicalTrials.gov |
What this trial studies
Children aged 6–15 with idiopathic scoliosis and biochemical vitamin A deficiency or insufficiency are randomized at a pediatric spine center to receive either daily oral vitamin A (2000 IU) for six months plus a standardized nutritional education session or the same education session alone. Participants are skeletally immature (Risser 0–3) with major Cobb angles under 40° at baseline and undergo standing full-spine X-rays at baseline and follow-up to measure curve magnitude and new curve development. The intervention aims for sustained biochemical correction of vitamin A levels while controlling for the effects of health education. Safety exclusions include prior high-dose vitamin A, signs of severe deficiency, or serum retinol above 0.70 mg/L to avoid hypervitaminosis A.
Who should consider this trial
Good fit: Ideal candidates are children 6–15 years old with idiopathic scoliosis, biochemical vitamin A deficiency or insufficiency, Risser 0–3, and a major Cobb angle less than 40° who can attend clinic visits and X-rays.
Not a fit: Children without low vitamin A, with advanced skeletal maturity, very large curves (≥40°), or with severe comorbid conditions are unlikely to benefit from this intervention.
Why it matters
Potential benefit: If successful, correcting vitamin A insufficiency could slow curve progression or reduce the likelihood of new scoliosis in susceptible children.
How similar studies have performed: This approach is largely novel for idiopathic scoliosis, with only preliminary unpublished and small pilot data suggesting an association between low vitamin A and scoliosis risk.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age between 6 and 15 years. 2. Biochemically confirmed vitamin A deficiency (serum retinol \< 0.20 mg/L) or insufficiency (serum retinol 0.20-0.29 mg/L). 3. Has undergone radiographic evaluation (standing full-spine X-ray) for idiopathic scoliosis at the initial clinic visit. 4. Skeletally immature (Risser sign 0-3) with a major Cobb angle \< 40 degrees at baseline. 5. Written informed consent/assent provided by the participant and legal guardian. Exclusion Criteria: 1. Unwillingness or inability to comply with all study procedures and follow-up visits. 2. Plans to relocate outside the study area within the next 24 months. 3. Previous high-dose vitamin A supplementation therapy within the past 12 months. 4. Clinical signs of severe vitamin A deficiency syndrome (e.g., xerophthalmia, Bitot's spots). 5. Serum vitamin A level \> 0.70 mg/L (to avoid risk of hypervitaminosis A). 6. Severe chronic health conditions that could confound study outcomes, including but not limited to: * Known syndromic, neuromuscular, or congenital musculoskeletal causes of scoliosis. * History of spine surgery or significant spinal trauma. * Spinal tumor. * Leg length discrepancy \> 20 mm. * Other severe chronic diseases (e.g., poorly controlled diabetes, chronic liver or renal disease, malabsorption syndromes). * Severe obesity (body mass index z-score ≥ 3).
Where this trial is running
Wenzhou, Zhejiang
- The Second Affiliated Hospital of Wenzhou Medical University — Wenzhou, Zhejiang, China (Recruiting)
Study contacts
- Study coordinator: Xiangyang Wang, MD
- Email: Xiangyangwang@wmu.edu.com
- Phone: 86-13506663458
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.